Diabetes

Diabetes complications can lead to multiple comorbidities of the microvasculature and microvasculature including neuropathy…

Diabetes is one of the most common chronic conditions. It affects a global population of approximately 425 million. The prevalence…

Non-communicable diseases (cardiovascular diseases, hypertension, and diabetes) and comorbid common mental disorders are of public health concern because of their high morbidity and mortality rates. The authors undertook a systematic review of studies that reported the prevalence of common mental disorders among non-communicable diseases, specifically in India.

Prediabetes is a state of hyperglycaemia, impaired glucose tolerance, and is associated with weight loss often preceding Type 2 Diabetes…

Ard opened his talk by discussing the role of nutrition in T2DM. For some individuals, T2DM is a consequence of excess weight gain. The…

‘The Ominous Quartet’ represents four glycaemic disorders at the centre of cardiovascular diseases in diabetes, including ambient…

More than two decades ago, during the 3-year course as a post-graduate trainee of internal medicine and working in the largest medical college of Asia, that too under a renowned diabetologist, I was exposed to handling an extremely busy diabetes clinic catering several hundred patients a day, with a limited backup supporting staff. I think this was the trigger for my keen interest in pursuing post-doctoral course in diabetes and endocrinology. Even during my undergraduate days, there was a notion that if you do not fully know how to treat diabetes and tuberculosis in India, you have not learnt anything about internal medicine. The field of diabetology was set to hold a great promise since a lot was left to be learnt about the complex pathophysiology including the management of Type 2 diabetes mellitus (T2DM).

I have always been interested in physiology and how the body works, and, during my PhD, I had the opportunity to work with models of glucose dysregulation. Many of us take the ability to control our blood glucose within a ‘healthy euglycaemic’ range for granted. It is only when things go wrong that we appreciate how complex this process is. My recent work has focused on Type 1 diabetes mellitus (T1DM), where individuals cannot produce their own insulin and rely on insulin replacement therapy.